Auli Toivanen

6.0k total citations
193 papers, 4.7k citations indexed

About

Auli Toivanen is a scholar working on Genetics, Rheumatology and Immunology. According to data from OpenAlex, Auli Toivanen has authored 193 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Genetics, 53 papers in Rheumatology and 40 papers in Immunology. Recurrent topics in Auli Toivanen's work include Yersinia bacterium, plague, ectoparasites research (50 papers), Rheumatoid Arthritis Research and Therapies (40 papers) and Pharmacological Effects of Natural Compounds (36 papers). Auli Toivanen is often cited by papers focused on Yersinia bacterium, plague, ectoparasites research (50 papers), Rheumatoid Arthritis Research and Therapies (40 papers) and Pharmacological Effects of Natural Compounds (36 papers). Auli Toivanen collaborates with scholars based in Finland, United States and Denmark. Auli Toivanen's co-authors include Paavo Toivanen, Kaisa Granfors, R. Lahesmaa-Rantala, R Merilahti-Palo, R. Saario, Sirpa Jalkanen, R. von Essen, Matti K. Viljanen, Rauli Leino and Olli Vainio and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Auli Toivanen

190 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Auli Toivanen Finland 34 1.4k 1.3k 1.2k 727 725 193 4.7k
Kaisa Granfors Finland 42 1.5k 1.1× 2.4k 1.9× 1.4k 1.2× 840 1.2× 701 1.0× 183 5.4k
Paavo Toivanen Finland 50 2.1k 1.6× 842 0.7× 1.7k 1.4× 2.0k 2.7× 1.2k 1.7× 234 7.3k
Charles A. Mebus United States 42 643 0.5× 793 0.6× 714 0.6× 497 0.7× 725 1.0× 130 5.4k
Martin J.H. Nicklin United Kingdom 36 1.7k 1.3× 450 0.4× 703 0.6× 2.7k 3.7× 681 0.9× 50 5.9k
Gary R. Klimpel United States 41 3.1k 2.3× 169 0.1× 581 0.5× 1.3k 1.8× 1.2k 1.6× 110 6.0k
Martin Giedlin United States 23 5.3k 3.9× 378 0.3× 865 0.7× 2.0k 2.7× 1.1k 1.5× 40 9.2k
Thierry Olivry United States 42 900 0.7× 413 0.3× 489 0.4× 629 0.9× 960 1.3× 262 6.7k
S F Wolf United States 30 6.1k 4.5× 206 0.2× 1.1k 1.0× 1.6k 2.1× 1.5k 2.0× 40 8.8k
Gianfranco Del Prete Italy 52 5.3k 3.9× 691 0.5× 415 0.4× 789 1.1× 2.0k 2.7× 112 9.6k
Maria Wysocka United States 36 5.6k 4.1× 296 0.2× 464 0.4× 1.3k 1.7× 2.1k 2.8× 59 8.7k

Countries citing papers authored by Auli Toivanen

Since Specialization
Citations

This map shows the geographic impact of Auli Toivanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Auli Toivanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Auli Toivanen more than expected).

Fields of papers citing papers by Auli Toivanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Auli Toivanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Auli Toivanen. The network helps show where Auli Toivanen may publish in the future.

Co-authorship network of co-authors of Auli Toivanen

This figure shows the co-authorship network connecting the top 25 collaborators of Auli Toivanen. A scholar is included among the top collaborators of Auli Toivanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Auli Toivanen. Auli Toivanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nurmi-Lüthje, Ilona, et al.. (2018). Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland (vol 29, pg 837, 2018). STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations
2.
Toivanen, Auli. (2008). Alphaviruses: an emerging cause of arthritis?. Current Opinion in Rheumatology. 20(4). 486–490. 41 indexed citations
3.
Toivanen, Auli. (2001). Bacteria-Triggered Reactive Arthritis. Drugs. 61(3). 343–351. 15 indexed citations
4.
Nejentsev, Sergei, et al.. (2001). HLA haplotype analysis in Finnish patients with rheumatoid arthritis. Arthritis & Rheumatism. 44(2). 315–322. 26 indexed citations
5.
Toivanen, Auli & Paavo Toivanen. (2000). Reactive arthritis. Current Opinion in Rheumatology. 12(4). 300–305. 23 indexed citations
6.
Lähteenoja, Hannu, Auli Toivanen, M. Viander, et al.. (2000). Increase in T-Cell Subsets of Oral Mucosa: a Late Immune Response in Patients with Treated Coeliac Disease? *. Scandinavian Journal of Immunology. 52(6). 602–608. 14 indexed citations
7.
Toivanen, Paavo & Auli Toivanen. (1999). Two forms of reactive arthritis?. Annals of the Rheumatic Diseases. 58(12). 737–741. 24 indexed citations
8.
Reijonen, Helena, Jorma Ilonen, Katja Anttila, et al.. (1997). Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis. Annals of the Rheumatic Diseases. 56(1). 37–40. 20 indexed citations
9.
Toivanen, Auli & Paavo Toivanen. (1997). Reactive arthritis. Current Opinion in Rheumatology. 9(4). 321–327. 5 indexed citations
10.
Immonen‐Räihä, Pirjo, et al.. (1994). A statistical analysis system macro for age-standardized incidence rates. Computer Methods and Programs in Biomedicine. 44(2). 79–83. 2 indexed citations
11.
Toivanen, Paavo & Auli Toivanen. (1994). Does <i>Yersinia</i> Induce Autoimmunity?. International Archives of Allergy and Immunology. 104(2). 107–111. 14 indexed citations
12.
Hietarinta, M., S. Koskimies, Olli Lassila, Esa Soppi, & Auli Toivanen. (1993). FAMILIAL SCLERODERMA: HLA ANTIGENS AND AUTOANTIBODIES. Lara D. Veeken. 32(4). 336–338. 8 indexed citations
13.
Tertti, Risto, et al.. (1989). Clinical manifestations ofYersinia pseudotuberculosis infection in children. European Journal of Clinical Microbiology & Infectious Diseases. 8(7). 587–591. 37 indexed citations
14.
Kellokumpu‐Lehtinen, Pirkko, E Nordman, & Auli Toivanen. (1989). Combined interferon and vinblastine treatment of advanced melanoma: evaluation of the treatment results and the effects of the treatment on immunological functions. Cancer Immunology Immunotherapy. 28(3). 213–7. 11 indexed citations
15.
Eskola, J., et al.. (1988). Serum IgA deficiency and anti-IgA antibodies in pernicious anemia. Clinical Immunology and Immunopathology. 46(1). 55–60. 7 indexed citations
16.
Eerola, Erkki, Kari Pulkki, Lauri J. Pelliniemi, et al.. (1988). Arthritis‐associated changes in flow cytometric characteristics of cultured synovial fibroblasts. Arthritis & Rheumatism. 31(3). 339–347. 10 indexed citations
17.
Leino, Rauli, R. Lahesmaa-Rantala, Kaisa Granfors, & Auli Toivanen. (1988). IgA class antibodies against Yersinia enterocolitica O:3 in patients with thyroid disease. European Journal of Endocrinology. 119(1). 81–84. 7 indexed citations
18.
Toivanen, Auli & Paavo Toivanen. (1987). Avian immunology : basis and practice. CRC Press eBooks. 144 indexed citations
19.
Toivanen, Auli. (1976). Pulmonary asbestosis and autoimmunity.. BMJ. 1(6011). 691.2–692. 4 indexed citations
20.
Toivanen, Paavo, Auli Toivanen, & Pekka Tamminen. (1973). Presence of the early post bursal stem cell and chicken spleen bone marrow and thymus. Scandinavian Journal of Immunology. 2(4). 460. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026